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Abstract
Embryonic stem cells (ESC) and induced pluripotent stem cells (iPSCs) present a great opportunity to treat and
model human disease as a cell replacement therapy. There is a growing pressure to understand better the signal
transduction pathways regulating pluripotency and self-renewal of these special cells in order to deliver a safe and
reliable cell based therapy in the near future. Many signal transduction pathways converge on two major cell
functions associated with self-renewal and pluripotency: control of the cell cycle and apoptosis, although a
standard method is lacking across the field. Here we present a detailed protocol to assess the cell cycle and
apoptosis of ESC and iPSCs as a single reference point offering an easy to use standard approach across the field.
Introduction
Human embryonic stem cells (hESC) have been derived
from the inner cell mass of blastocytes and can be main-
tained in vitro indefinitely with the addition of fibroblas-
tic growth factor 2 (FGF2) [1]. It has been shown that a
combination of three or four pluripotency transcription
factors; Oct4, Sox2 and KLf4, with or without Myc can
reprogram somatic cells to generate induced pluripotent
stem cells (iPSC) [2,3]. Recently, it has been shown that
loss of p53 function can enhance the efficiency of repro-
gramming, suggesting that the cell cycle is a rate limit-
ing step in the reprogramming process [4-10]. Given the
important role of the cell cycle and apoptosis in pluripo-
tent cells, a detailed protocol that standardises the tech-
nique of measuring cell cycle and apoptosis in
pluripotent cells across the field is called for.
T h ec e l lc y c l eo fm o u s eE S C sa n dt oal e s s e re x t e n t
hESCs has been well described [11-13]. The cell cycle
regulatory machinery of ESC including the Cyclin
families A, E, D, and B and their kinases CDK2, 4 and
6, are not regulated in a cyclic fashion, with the excep-
tion of cyclin B [11,12]. Of the core machinery, cyclin
A/E/CDK2 are regarded as constitutively on in mouse
ESC driving an almost non-existent G1 phase into S
phase, in which 60-70% of ESC are present. Conse-
quently, the rate of ESC proliferation is much faster
with an average cycle lasting just twelve hours compared
to somatic cells [13,14]. A recent study functionally
demonstrated that Cyclin A regulates pluripotency but
is redundant in fibroblasts suggesting it is a pluripotent
associated cell cycle kinase [15]. Many of the peripheral
genes that control cell cycle such as p16
INK4a are
thought to be inactive, resulting in a different regulation
of cell cycle in mouse ESC [16]. It is evident that there
are many differences between somatic and pluripotent
cells; however, little is known about the role of the cell
cycle in maintaining ESC or iPSC in culture. Much less
is known about control of apoptosis in ESC or iPSC
while under in vitro conditions.
Here we describe a protocol how to measure cell cycle
and apoptosis in pluripotent stem cells (hESC and iPS
cells) that could be used, for example, following infec-
tion with a lentivirus to manipulate cell cycle function
of ESC or iPSC in vitro. Detailed protocols how to make
lentivirus have been published previously [17-19]. We
describe a standard method to measure cell cycle profile
by FACs in hESC and iPS cells using EdU substrate; and
apoptosis using DilC mitochondrial membrane method
in the same sample concurrently. The use of DNA dyes
and EdU staining (an advance on BRDU staining) has
been discussed extensively by Cappella et al and Hame-
lik et al [20,21]. In addition we describe a list of working
antibodies for cell cycle and apoptosis proteins by wes-
tern blot methodology. The protocol described here is
applicable to any human or animal pluripotent stem cell
and enables “getting the most” from your cell cycle and
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prehensive standardised protocol across the field of
pluripotent stem cells.
Materials
For detailed methods on how to make iPSCs as well as
how to infect such cells using concentrated lentiviruses
and supernatant retroviruses including reagents, equip-
ment and set up please refer to recently published work
[17-19].
Reagents
￿ Human and mouse embryonic stem cells (ESC)
CAUTION: Check ethic issues with your specific insti-
tute for use of hESC.
￿ Human or mouse induced pluripotent stem cells
(iPSC)
￿ Mitotically inactivated mouse embryonic fibroblasts
(irMEFs)
￿ Mitotically inactivated human foreskin fibroblasts
(irHFFs) (ATCC, cat. no. CRL-2429)
￿ 0.1% (wt/vol) Gelatin solution (Millipore, cat. no. ES-
006-B)
￿ Matrigel (Mg, BD Biosciences, cat. no. 356234)
￿ Dulbecco’s PBS, without Ca2+ or Mg2+ (PAA
laboratories GmbH, cat. no. H15-002)
￿ DMEM (Invitrogen, cat. no. 21969-035)
￿ KO-DMEM (Knockout DMEM, Invitrogen, cat. no.
10829-018)
￿ Fetal calf serum (FCS, Perbio, Hyclone, cat. no.
CH30160.03)
￿ Heat-inactivated fetal bovine serum (FBS, Invitrogen,
cat. no. 10270-106)
￿ Knockout Serum Replacement (KO-SR, Invitrogen,
cat. no. 10828-028)
￿ Trypan Blue stain (Invitrogen, cat. no. 15250-061)
￿ 20% (wt/vol) Human serum albumin (HSA, Instituto
Grifols SA, cat. no. 670612)
￿ GlutaMAX (Invitrogen, cat. no. 35050-038)
￿ Minimum essential medium Eagle’sn o n e s s e n t i a l
amino acids, 100 × (Lonza, cat. no. BE13-114E)
￿ Nucleosides, 100 × (Millipore, cat. no. ES-008-D)
￿ Penicillin/streptomycin (Invitrogen, cat. no. 15140-
163)
￿ Lipofectamine 2000 (Invitrogen)
￿ 50 mM 2-mercaptoethanol (Invitrogen, cat. no.
31350-010)
￿ Basic fibroblast growth factor (Peprotech cat. no.
100-18B) (see REAGENT SETUP)
0.25% (wt/vol) Trypsin/EDTA (Invitrogen, cat. no.
25200-056)
0.05% (wt/vol) Trypsin/EDTA (Invitrogen, cat. no.
25300-054)
￿ Polybrene (10 mg ml-1, Millipore, cat. no. TR-1003-
G)
￿ FuGENE 6 transfection reagent (Roche Applied
Science, cat. no. 11 988 387 001)
￿ DMSO (Sigma, cat. no. D4540)
￿ MitoProbe DilC assay kit for flow cytometry
(M34151)
￿ Invitrogen Click iT Edu cell proliferation assay kit
for flow cytometry (A10202).
Equipment
￿ DakoCytomation MoFlo High-performance cell sorter
equipped with 3 lasers, an Innova 90C UV laser from
Coherent, a red diode 635nm and a Lytcyt200s 488 nm
solid-state laser. The PMT detectors used are Hama-
matsu -15.
￿ Leica SP5 AOBS confocal microscope
￿ Water Bath set to 37°C.
￿ Class-II cabinet with aspirator for tissue culture
(Telstar Bio-II-A)
￿ Class-II cabinet with space for stereomicroscope
(Telstar Bio-II-A/G)
￿ Aspirator tube assembly (Sigma, cat. no. A5177)
￿ Stereomicroscope (Olympus SZX12, Olympus)
￿ Low-end color video camera (JVC TKC1481BEG)
￿ Low-end 8-inch LCD display (BOMAN TV304)
￿ Inverted tissue culture microscope with phase con-
trast and epifluorescence, with ×5, ×10, ×20 and ×40
objectives (Leica DMIL, Leica)
￿ Thermostatized tissue culture centrifuge and swing-
ing rotor with adapters for 15-ml and 50-ml tubes and
microplates (Beckman Coulter Allegra X-12R centrifuge
with SX4750A rotor, Beckman Coulter)
￿ High-speed centrifuge and swinging rotor (Beckman
Coulter Avanti J-30I centrifuge with JS-24.38 rotor,
Beckman Coulter)
￿ Cell culture incubator set at 37°C, 5% CO2 (REVCO,
cat. no. RCO3000D-9-VBC)
￿ Cell culture incubator set at 32°C, 5% CO2 (REVCO,
cat. no. RCO3000D-9-VBC)
￿ Cell culture incubator set at 37°C, 5% CO2 and 5%
O2 (REVCO, cat. no. RTG5000D-9-VBC)
￿ Microcentrifuge (Eppendorf 5424, Eppendorf)
￿ Tissue culture dish, 100 and 150 mm
￿ Tissue culture flasks, T75 and T150
￿ Tissue culture plates, six-well
￿ Conical tubes, 15 and 50 ml
￿ Screw-cap microcentrifuge tubes (Sarstedt, cat. no.
72.692.005)
￿ Polyallomer centrifuge tubes, 13 × 51 mm (Beckman,
cat. no. 326819)
￿ Cover slips
￿ Stripper micropipette (Mid Atlantic, cat. no. MXL3-
STR)
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mid-atlantic devices.
￿ Cryo 1°C Freezing Container, ‘Mr. Frosty’ (Nalgene,
cat. no. 5100-0001)
￿ Slide flask (Nunc, cat. no. 170920)
￿ Bottle-top filter system 0.22 μm, 500 ml (Millipore,
cat. no. SCGPU05RE)
￿ Filter, Mille-HV PVDF (polyvinylidene fluoride) (0.45
μm, Millipore, cat. no. SLHV033RS)
￿ Invitrogen western blot and transfer equipment.
REAGENT SETUP
Basic fibroblast growth factor (bFGF)
After spinning briefly, resuspend the contents of the vial
with 10 ml of 0.2% (wt/vol) HSA in PBS. The final con-
centration of bFGF is 100 μg/ml. Prepare 50 μla n d1 0 0
μl aliquots in screw-cap microcentrifuge tubes and store
at minus 20°C for up to 6 months. Avoid more than
three freeze thaw cycles.
10 mM EdU solution
Add 4 ml of DMSO to EdU substrate, mix well and ali-
quot into 50 ul batches and store at -20C.
Saponin based wash buffer
Add 1 ml of Saponin from Click iT kit to 9 mls of PBS
for working buffer.
DAPI solution
CAUTION: DAPI is a known mutagen and should be
handled with care. The dye must be disposed of safely
and in accordance with applicable local regulations.
0,1M Tris Base pH7,4 (from Sigma ref. T1503; MW =
121.14)
0,9% or 150 mM NaCl (from Sigma ref. S3014; MW =
58.44)
1mM CaCl2 (from Sigma ref. C2661; MW = 110.986)
0.5 mM MgCl2 (from Merk ref. 1.05833.1000; MW =
203.30) - 6H2O
0.2% BSA (from Sigma ref. A4503)
0.1% Nonidet P40 (from Sigma ref. I8896) - Igepal
10 μg/mL DAPI (from Invitrogen ref. D21490)
Propidium Iodide (P4170, Sigma-Aldrich) solution
(0.5 mg/ml in PBS with 0.1% sodium azide, pH approxi-
mately 7.4)
BOX 1
HES media (for culture of hESc and hIPSC on ir MEF or
irHFF feeder layers)
-Knockout DMEM (Gibco #10829-018) (4°C).
-Knockout Serum Replacement (KSR) (Gibco
#10828-028) (-20°C).
- Non-Essetial Amino Acids 100× (Gibco) (4°C).
-2-Mercaptoethanol 50 mM (Gibco #31350-010) (4°
C).
-Penicillin (10.000U/ml)/Streptomycin (10.000 μg/
ml) (100X).
(Gibco #15140-122) (-20°C).
-GlutaMAX 200 mM (100X) (Gibco #35050-038)
(-20°C).
- basic Fibroblastic Growth factor 100 μg/ml (Pepro-
tech) (-20°C).250 ml
-Knock-Out DMEM 193,5 ml
-20% Knock-Out serum replacement 50 ml
-1× Non-Essetial Amino Acids 2,5 ml
-50 U/ml-50 μg/ml Penicillin/Streptomycin (P/
S) 1,25 ml
-1× GlutaMAX 2,5 ml
-50 μM 2-Mercaptoethanol 250 μl
-8 ng/ml basic Fibroblastic Growth factor 20 μl
HUES media (for culture of hESC or hiPSC independent of
feeder layers on matrigel)
-Knockout DMEM (Gibco #10829-018) (4°C).
-Knockout Serum Replacement (KSR) (Gibco
#10828-028) (-20°C).
- Non-Essetial Amino Acids 100× (Gibco) (4°C).
-2-Mercaptoethanol 50 mM (Gibco #31350-010) (4°
C).
-Penicillin (10.000U/ml)/Streptomycin (10.000 ug/
ml)(100X)
(Gibco #15140-122) (-20°C).
-GlutaMAX 200 mM (100X) (Gibco #35050-038)
(-20°C).
- basic Fibroblastic Growth factor 100 μg/ml (Pepro-
tech) (-20°C).
-Human albumin 20% (Grifols) (RT).300 ml
- Knockout DMEM 250 ml
-10% Knockout Serum Replacement 30 ml
-1× Non-Essetial Amino Acids 3 ml
-50 μM 2-Mercaptoethanol 0,3 ml
-1× penicillin/Streptomycin (100 U/ml, 100 μg/
ml) 3 ml
-1× GlutaMAX 200 mM 3 ml
-10 ng/ml basic Fibroblastic Growth factor 30 μl
-Human albumin 20% 7.5 ml
The use of conditioned media for hESC or hiPSC on
matrigel is essential. To make conditioned media, simply
add HEUS media to irMEFS over night and the next day
fliter through a millipore 0.45 uM filter onto cells.
BOX 2
Plating irHFF or irMEF cells
The day before plating ES[4] cells seed irradiated feeders
HFF (ATCC) on gelatinized plates. For a 100 mm plate:
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(Chemicon). Incubate at least 30 min at 37°C (you can
also leave the plate with gelatin overnight at 37°C).
Aspirate the gelatin solution and let the plate dry under
the hood. 2. Plate 4 × 10
6 cells/100 mm plate in DMEM
+10%FBS, 1 × Glutamax, 1 × Pen/Strep.
Plating hESC or hiPSC by trypsinization on matrigel
coated plates
When the colonies get big enough and start to touch
other colonies is time to passage them. Coating of plates
using 1:15 diluted Growth Factor Reduced (GFR) matri-
gel (from BD) in Knockout DMEM is done the day
before at 4°C and has been described previously [19].
￿ Aspirate media and wash cells with PBS.
￿ Add 1 ml of 0,05% trypsine-EDTA and incubate at
37°C for 2-5 minutes.
￿ Add 9 ml of HUES media and resuspend the cells:
￿ If you want a single cell suspension: perform a
complete trypsinization and pipette up and down
several times before plating.
￿ Plate the cells at the desired dilution, usually 1:6
dilution.
￿ Don’t change the media the following 48 hours
after plating.
￿ Change the media daily. Warm up just the needed
media each time.
PROCEDURE
Maintaining ESC and iPSC in culture using matrigel or
feeder layers
For hESC or iPSC on feeder layers, pluripotent cells can
be trypsinized and then separated during analysis based
on Forward Scatter (FSC). To maintain the line, cells
must be passaged using a scrapper via a video screen
linked to a stereomicroscope. Pluripotent cell colonies
are scrapped off the feeder layer, collected and split into
waiting feeder layers no more than 1:3 (for ES cells) and
1:10 (for iPS cells). For hESC or hiPSC maintained on
matrigel trypsinization is used (see box 2).
CRITICAL STEP: Proper cultivation of pluripotent
stem cells to keep cells healthy is essential because it
can affect growth rates dramatically, which can be seen
by some cell cycle analyses.
Assessment of cell cycle profile and apoptosis by Flow
Cytometry from the same sample
TIMING 3 hours.
We use the Invitrogen Click IT EdU kit for detection
of S phase with a modified protocol to give quicker and
easier to achieve results. We have tested many DNA
dyes and DAPI has been found best DNA staining for
pluripotent cells, especially when samples are left over-
n i g h ta t4 ° C( F i g u r e1 ) .F o ra s s e s s m e n to fa p o p t o s i sw e
use the MitoProbe DiLC assay kit (M34151). Pluripotent
cells can be split after EdU treatment into two tubes,
one for EdU assessment of cell cycle profile and the
other for assessment of apoptosis by DiLC (Mitochon-
drial membrane potential). In that way both measures
can be made from the same sample.
BOX 3
Getting the most out of your cell cycle flow cytometry
analysis
In addition to information about the percent of cells in
each of the phases of the cell cycle from EdU/DAPI
staining, extra information about the proliferative state
of the cells can be gleaned from the analysis.
(A). To the right of the percentages of each phase in
Flow Cytometry analysis histograms there are two
values (Figure 2). The first is the mean intensity of
signal from DAPI and the second is the intensity of
signal for EdU. The value for EdU is an indication of
how fast the cells are proliferating because the faster
they proliferate the more EdU they will absorb.
Therefore this number can act as a guide to the S
phase percentages when assessing how fast they are
proliferating. Be careful to ensure to use the same
concentration of EdU (10 uM) for the same time
period (45 minutes exposure to cells) with the same
density of pluripotent cells for all experiments. (B).
A second piece of information that can be taken
from the cell cycle Flow Cytometry analysis is a
clear separation of the 3 phases; G1, S and G2/M
phases (Figure 2). A clear separation is desirable
with the S phase high above the other phases. If this
is not the case it means that the EdU staining did
not work or the pluripotent cells are not healthy and
not proliferating normally (they could be quiescent.
Ensure to check that the pluripotent cells are healthy
before experiments.
Assessment of cell cycle profile by flow cytometry
CRITICAL STEP Make sure pluripotent cells are
between 40-60% confluent in all experiments because
cell density affects the final results (Figure 2).
1. Label the cells with EdU substrate by adding 10 ul
of 10 mM EdU solution to 10 mls of culture med-
ium in 10 cm plate of cells (a 1:1000 dilution) to
make a 10 uM final working concentration and incu-
bate for 45 minutes at 37°C 5% CO2. See Table 1.
2. We have found that for pluripotent cells leaving
the EdU for 45 minutes is optimal[4].
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sinization for pluripotent cells cultured on matrigel or
by scrapping the cells off the feeder layer to get pure
pluripotent cell population. Timing 10 minutes.
4. Wash the cells again in PBS and transfer cells to
Flow Cytometry tubes. Spin down at 1500 rpm for 2
minutes to form pellet. Remove PBS simply by turn-
ing tube upside down into a waste container with
one quick movement, drying the edges on paper to
remove drops at edge of tube. This leaves approxi-
mately 50 ul of PBS in the FACS tube.
CRITICAL STEP: Tapping the tube only once upside
is essential otherwise the cells will slide out.
CAUTION: EdU cocktail breaks down GFP signal that
may be expressed in genetically modified pluripotent
cells being used, but not the Alexa fluor dyes. Therefore
consider adding an anti-GFP AlexaFluor-488 conjugated
antibody step to cells before labelling with EdU cocktail
to retrieve the GFP signal.
5. Add 100 μl of Click IT fixative for 15 minutes R/
T and mix well by vortex.
6. Wash once 3 mls of PBS and pellet cells again at
1500 rpm for 2 minutes and discard wash buffer by
inverting the Flow Cytometry tube as described above.
7. Permeabilize the cells by adding 100 μl of saponin
based wash buffer for 30 minutes R/T.
8. Wash with 3 mls of saponin based wash buffer
and pellet cells again.
9. Add Click IT reaction cocktail and add 500 μl
per Flow Cytometry tube and incubate for 30 min-
utes R/T in the dark.
10. Wash once with PBS, pellet cells and add DAPI
solution and incubate overnight at 4°C and analyse
the following day for best results or leave at 4°C for
at least 2 h for immediate FACS analysis.
CRITICAL STEP: We have tried different DNA dyes
(PI, Hoechst33342, Click-iT EdU Cell Cycle 633-red,
7AAD, and in our hands the best cell cycle profiles in
DIFFERENTIATION 
Day 0                                      Day 3                                Day 9                             Day 15
G1 S G2/M G1 S G2/M G1 S G2/M G1 S G2/M
Jurkat Cells Human ESC#1 Human ESC#2 Human iPSC#1 Human iPSC#2
H258
DNA
Dye
DAPI
DNA
Dye
PI  or
7-AAD
DNA
Dye
Jurkat +PI Human ESC#1+ PI Human ESC#1 +7AAD
DAPI
DNA
Dye
A
B
Figure 1 Analysis of different DNA dyes in pluripotent cells. Panel A: Comparison of FACs histograms of four different DNA dyes, staining of
Jurkat cells, Human ESC and human IPS cells. We found that DAPI gave the best overall profile of the G1, S and G2/M phases of the cell cycle
across different cell types described in the figure. Panel B: FACs histograms of DAPI staining of mouse ESC at day zero (undifferentiated
pluripotent cells) and at different stages of differentiation using general differentiation cell culture conditions (Gelatin coated plates with 20%
FCS in DMEM). Note the dramatic changes in the overall profile of the G1, S and G2/M phases of the cell cycle with differentiation.
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peak came up when using DAPI.
11. Assess a minimum of 10000 events at levels
described in Table 2.
CRITICAL STEP: Check to ensure that you flow
cytometry machine has PMT detectors that are Hama-
matsu -15, which are very sensitive. If not higher
powers of 100-200 mW may be needed to detect
DAPI.
Mouse iPS cells (late passage) B Human ESC
Human IPS cells (early passage) Jurkat cells
Low density
Medium density
High density
Confluent
hESC density G0/G1 phase S phase G2/M phase
Low (20%) 13%  54%  29% 
Medium (50%) 16%  54%  22% 
High (75%)  16%  53%  22% 
Confluent (100%) 18%  53%  20% 
A
Figure 2 Analysis of cell cycle. Panel A: Photographs of hESC at different densities. The table below is an analysis of cell cycle profile using
EdU for 30 minutes at 10 uM. Note the differences in G1 and G2/M with different cell density. Using cells at 50-60% confluence is optimal.
Lower Panel: Histogram of hESC treated with BRDU demonstrating a 50-60% of cells in S phase. Panel B: Flow cytometry histograms of cell cycle
profile of hESC, human IPS cells, mouse IPS cells and Jurkat cells treated with EdU and DAPI. Note the red box highlights the mean intensity of
EdU signal that can also be used as an indicator of the proliferative state of the cells.
Table 1 Modified working volumes for Click IT cocktail for EdU analysis of S phase.
Reaction components for Click IT cocktail Number of reactions
25 1 0
10× Click-IT Reaction Buffer 87.5 ul 219 ul 438 ul
CuSO4 20 ul 50 ul 100 ul
Fluorescent dye 5 ul 12.5 ul 25 ul
10× Reaction buffer additive 10 ul 25 ul 50 ul
Water 877.5 ul 2193.5 ul 4387 ul
TOTAL volume 1 ml 2.5 ml 5 ml
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analysis
We have assessed two methods for measuring apoptosis
in pluripotent cells including DiLC and Annexin V. We
found that DiLC gave the best results. Annexin V is not
suitable for trypisination of pluripotent cells because it
causes false positives (see Figure 3 and Table 3).
TIMING 2 hours.
12. The other sample of pluripotent cells split from
the original is used to assess levels of apoptosis.
13. Use the MitoProbe DiLC Assay Kit for Flow
Cytometry (M34151) from Invitrogen to measure
mitochondrial membrane potential.
14. Tripsinize or scrape pluripotent cells from plate
and pellet cells by centrifuge and place in pre-
warmed (37°C) PBS.
CRITICAL STEP Maintain the cells at 37°C at all
times in a water bath for stable membrane potential.
Having access to a water bath in the flow cytometry
machine room is advised.
15. Wash cells again in 1 ml pre-warmed PBS in
Flow Cytometry tubes and pellet.
16. For control tubes add 1 uL of 50 mM CCCP and
incubate cells at 37°C for 5 minutes.
CRITICAL STEP: Including a CCCP (it is a meta-
bolic inhibitor) control is essential to clearly define
within the histogram analysis the cut-off between the
apoptotic and alive populations in the first experiments
and to determine that the apoptosis assay is working.
Adding CCCP causes loss of mitochondrial membrane
potential (MMP) and should cause a shift of cells out
of the top left where alive cells can be found (Figure
3).
17. Add 5 uL of 10 μMD i l C( c a nb ea d d e da ts a m e
time with CCCP for controls) and incubate at 37°C,
5% CO2 for 30 minutes).
18. Wash with 3 mls of pre-warmed PBS and pellet
cells and discard wash by tipping once and drying
edges (50 uL of solution is left with this method).
19. Resuspend cells with 100 uL of propidium iodide
(PI) solution and incubate for 15 minutes at 37°C.
20. Proceed to analyser to assess percent of cells
apoptotic/alive/dead (see Figure 3).
21. Assess a minimum of 10,000 events.
CRITICAL STEP: samples must be analysed immedi-
ately to ensure the membrane is preserved. Heating the
DAKO MoFlo flow cytometer tubing to 37°C is recom-
mended. With the MoFlo, the sample port can be set at
any temperature with a range 0°C- 40°. Because the 37°
C is important in order to maintain the MMP, taking
Table 2 MoFlo Instrument Settings the Flow Cytometry machine for detection of GFP, EdU and DAPI signals.
Laser Excitation wavelength & power Band Pass Filters used for collection of emitted fluorescence (wavelength/power)
Blue 488 nm at 30 mWatts Green emission - 530/30 (from anti-GFP/Alexa Fluor 488)
Ultra violet 351 nm at 20 mWatts Blue emission - 450/65 (from DAPI)
Red 633 nm at 35 mWatts Red emission - 670/20 (from Alexa Fluor 647 azide linked to EdU)
Alive
Apoptotic
Dead
hESC Jurkat Cells
hESC - Annexin V
Untreated Treated with
Cyclosporin A
50uM for 20hrs.
hESC - Annexin V
DilC1 DilC1
DilC1
DilC1
DilC1  + 
CCCP
DilC1  + 
CCCP
Figure 3 Analysis of Apoptosis using DiLC and PI.C o m p a r i s o n
of two different methods for measurement of apoptosis, DilC and
Annexin V in human ESC (pluripotent cells) or Jurkat cells
(Differentiated cells). Flow cytometry histogram of hESC assessed for
apoptosis levels using DiLC, which measures the mitochondrial
membrane potential. Note that the control ESC treated with CCCP
(with DiLC at the same time) to show the shift in signal,
demonstrating that the assay is working. Cyclosporin A was used in
Annexin V assays to induce apoptosis (50 uM for 20 hours).
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machine will help maintain valid results.
Western Blot methodology
We include a list of antibodies that have been tried and
tested for detecting cell cycle proteins and apoptosis
proteins in pluripotent cells (Table 4). These selected
antibodies, of some of the main cell cycle proteins, work
with resolving SDS gels of 4-12% using between10-15
μg of total protein unless specified in table 4. If non
resolving gels are used then use 8% gels for Rb, p107,
cdc27 and MDM2, which are 80 Kda or bigger proteins
and 12% SDS gels for all others. See Figure 4 for an
example of the expected results for pluripotent cells
Table 3 MoFlo Instrument Settings for detection of DilC and PI signal.
Laser Excitation wavelength & power Band Pass Filters used for collection of emitted fluorescence (wavelength/power)
Blue (PI) 488 nm at 30 mWatts Orange emission - 580/30 (from PI)
Red emission - 670/30 (from PI)
Red (DilC) 633 nm at 35 mWatts Red emission - 670/20 (from DilC)
Table 4 Tested and working antibodies for analysis of
cell cycle and apoptosis by western blot methodology.
Antibody
name
Company and Cat
#
Dilution and expected size
(KDa).
P53 sc-126(DO-1)
mouse
1:1000 5%milk/TBS. 53 KDa
P19ARF R562 Abcam Rabbit 1:1000 5%milk/TBS 25 Kda (30-
50 μg)
P16INK4a M-156 (sc-Rabbit) 1:1000 5%milk/TBS 16 Kda
Rb C15 (sc rabbit) 1:1000 5%milk/TBS 105 KDA
P107 C18 (sc Rabbit) 1:1000 5%milk/TBS. 107 KDa
Cyclin A C19 (sc-rabbit) 1:1000 5%milk/TBS 54 Kda
Cyclin A1 H-230 (sc rabbit) 1:1000 5%milk/TBS 54 Kda
Cyclin A2 Epitomics E399
(rabbit)
1:500 5%milk/TBS 54 Kda
Cyclin B1 Sc-245 (mouse) 1:1000 5%milk/TBS 60 Kda
Cyclin D1 H-295 (sc rabbit) 1:1000 5%milk/TBS 34 KDa
Cyclin D2 M20 (sc rabbit) 1:1000 5%milk/TBS 34 KDa
Cyclin E M20 (sc rabbit) 1:1000 5%milk/TBS 53 KDa
E2F1 Sc-251 (sc mouse) 1:1000 5%milk/TBS 55 KDa
P21CIP F5 (sc mouse) 1:1000 5%milk/TBS 21 KDa
P27KIP (M-197) sc776
rabbit
1:1000 5%milk/TBS 27 KDa
CDK4 C22 (sc rabbit) 1:1000 5%milk/TBS 34 KDa
CDK2 H-298 (sc rabbit) 1:1000 5%milk/TBS 34 KDa
PCNA PC-10 (sc. Mouse) 1:1000 5%milk/TBS 36 KDa
MDM2 Abcam 2A10
(mouse)
1:1000 5%milk/TBS 80 KDa(30-50
μg)
Cleaved
Casapse 3
Cell sign (rabbit)
#9664
1:1000 5%milk/TBS 18 KDa
Cdc27 C4 (sc mouse) 1:1000 5%milk/TBS 102 KDa
TIMING: 1 week.
A
Figure 4 Western blot analysis of cell cycle proteins.W e s t e r n
blot of fourteen cell cycle antibodies described in table 4 using
irradiated MEFs as a control and undifferentiated human ESC
protein. Alpha-tubulin used as a loading control and Oct4 is used to
determine pluripotent state. Note: a comprehensive analysis such as
this one can be achieved in one week. sc: Santa Cruz; Cell Sign: Cell
Signal antibodies.
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four lysates can be loaded twice on one gel, with protein
molecular weight markers and four gels run at the same
time (two gels per container). Each membrane can be
blotted twice for two different antibodies from different
species (i.e. first with mouse antibodies, and developed
and then re-blotted with the rabbit primary antibodies
and developed again) and a final time for alpha tubulin
as a loading control (not listed). Therefore, up to 16
antibodies can be tested from the 4 gels using between
40 and 60 μg of total protein. If manipulating a cell
cycle gene by gain of function (cDNA) or loss of func-
tion (shRNA), then protein lysates can be run alongside
the ESC lane to determine the overall effect on core cell
cycle protein expression levels.
Discussion
Accurate cell cycle analysis has to be based on data from
cells handled in a manner in which the least variation
between experiments occurs. In our hands the reliability
and validity of the described method for measurement of
apoptosis and cell proliferation in the same sample is
very good. In the past other methods have been devel-
oped to measure cell proliferation that provide an alter-
native approach (see trouble shooting table 5).
Specifically, the use of other DNA dyes may improve the
method in different laboratories with different machines.
Other DNA specific dye, such as propidium iodide (PI)
can be added to the labelled cells for two-parameter ana-
lysis of EdU. We settled on DAPI (overnight at 4°C) giv-
ing the most reliable results. In our experience with EdU
stainings for flow cytometry analysis, the CVs have
remained low and reproducible with DAPI staining and
not 7-AAD (a modification from the kit). To achieve this
we recommend that factors such as cell culture condi-
tions are maintained well, exposure time of substrate and
concentration (as well as storage of substrate) is main-
tained well and that cell density is equal between experi-
ments (see Figure 1). Other methods for assessment of
cell cycle have been published before. Krishan and
Hamelik have modified the EdU procedure as an alterna-
tive method to the one we have described (20). In com-
parison to our method, the method involves a more
laborious step of isolation of cell nuclei. Moreover, the
requirements and complexicity of the method is more
demanding. Therefore, to maintain simplicity and ease in
use of the protocol with low CVs we prefer to use DAPI
staining with EdU, and give the same results compared to
using BRDU (see Figure 2).
We chose EdU click IT kit over standard BRDU stain-
ing for S phase analysis because it gave reliable results
and was quicker to complete with the same results (Fig-
ure 2). It is important to note that the Click-it method
breaks down GFP signal so we recommend to use an
anti-GFP antibody to recognize GFP expression, since it
uses copper sulfate and ascorbate to develop a signal.
Other methods have suggested to fix the cells in dilute
paraformaldehye which keeps the GFP intact prior to
staining (21). We agree that fixing cells with dilute par-
aformaldehyde can preserve the GFP signal, however in
our hands, using an anti-GFP AlexaFluor-488 antibody,
a flurochrome that is not degraded during the reaction
cocktail step, helps to retrieve the GFP signal, a signifi-
cant advantage with pluripotent cells that are so often
hard to infect/transfect. Given that ESC are notoriously
difficult for gain and loss of gene function studies,
retrieving the GFP signal with an Alexaflour 488 GFP
antibody, gives an advantage to attaining the best results
form flow cytometry work.
Flow Cytometry machines available to researchers
from lab to lab will vary and that different machines will
r e q u i r ed i f f e r e n tp o w e rs e t t i n g s .T h em a c h i n eu s e di n
this protocol is a High Performance MoFlo Cell sorter.
The MoFlo is equipped with 3 lasers, an Innova 90C
UV laser from Coherent, a red diode 635 nm and Lyt-
cyt200s 488 nm solid-state laser. The PMT detectors
used are Hamamatsu -15; this is the most sensitive
model and therefore low power levels at 30 mW are
used. If we work with 100-200 mW of power the signal
would be out of range. The best resolution of DNA sig-
nals may require more power using different machines;
however, this would depend on DNA dye used. For
example Hoechst dye exclusion assays to identify the
side population in a bone marrow just require 20-30
mW of UV power using a machine not equipped with a
Hamamatsu-15 detector.
Table 5 Troubleshooting
Step Problem Possible reason and solution
Low number of cells in S Phase EdU substrate incubation too short or batch of substrate used too many times. Use fresh aliquoted
EdU and incubate 15-30 minutes longer.
No distinct G1/S/G2M phases Cells not healthy or DAPI staining not working. Check that cells look healthy before starting
experiment and leave DAPI staining overnight at 4°C (in the fridge). Also consider using a modified
method using Hamelik and Krishan protocol by lysing cells (Hypotonic solution) for 1 minute followed
by centrifugation and then using EdU reaction (Click iT)[20].
DilC % apoptosis lower than
expected or not working.
Check with CCCP control there is a shift in DilC positive cells to negative. Keep cells at 37°C at all
times throughout the procedure and analyse immediately following PI staining.
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Page 9 of 11The faster cells proliferate when the cells are exposed
to BrdU or EdU for a fixed amount of time means more
cells labeled in late S, G2 or M phases. The main data
from EdU staining is S phase percentages but we thought
to also highlight that the mean intensity of signal can
also be used a secondary guide as well. When working
with a fixed amount of time and EdU concentration as
recommended in our protocol, the difference in the EdU
Signal to Noise ratio (S/N) can be directly related with
h o wf a s tt h e ya r eg r o w i n g .T h em o r et i m ee x p o s u r ea n d
the more concentration of EdU the higher the S/N ratio
and for this reason it is important to use pluripotent cells
at around 50-60% confluency, the same concentration of
EdU and also the same incubation time for all the treated
samples. We recommend that 10 uM EdU and 45 min-
utes to be used across the field for pluripotent cells. In
that way coefficient of variation can be calculated intra-
laboratory for many different pluripotent cell lines and
we have found very little variation between experiments
when this protocol is followed correctly.
Conclusions
At the end of the protocol a comprehensive analysis of
the percent of cells in G0/G1 phase, S phase and G2/M
phase should reveal an expected percentages of cells in
each phase as: 15%/65%/20% +/- 5%, respectively.
Changes greater than 5% in the G1 or G2/M phases
between samples of interest are considered significant.
Further evidence of an effect on cell cycle can be done
by performing a proliferation growth curve to show dif-
ferences more clearly. In our experience, differences
even less than 10% in S phase can be seen in prolifera-
tion curves maintained for over 2 to 3 weeks. Western
Blot analysis should reveal a protein expression for the
main cell cycle proteins as seen in Figure 4. Apoptosis
measurements by FACs should give a normal range of
70-75% of cells alive, 20% in transition and 5-10% apop-
tosis using DilC combined with PI methods. Overall,
this protocol will give rise to a detailed analysis of the
cell cycle and apoptosis status in human and mouse
pluripotent cells, offering a standardized approach
across the field. For more details of making lentivirus
and infection of ESC, please see previous published
work from our group (17-19).
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